Search results for: 'partners of frost & Sullivan'
- Did you mean
- partner of frost sullivan
- Related search terms
- frost amp sullivan's accountsignout helpcontactsitemap healthcare home research events blog forum peerconnect tags switch community
- frost amp sullivan believes that global nsps are investing between 50 billion and (6(6 billion) annually on their mobile and wireles
- Sullivan Product Leadership Award - The Global EV Battery Testing Industry
- Frost Radar™: Go-to-Market Intelligence and Activation Platforms, 2026
- Frost & Sullivan GIC Malaysia Sdn. Bhd. (2025). Independent market research on the food and beverages services industry in Malay
-
17 Nov 2021  |  Global  |  Market Research
Global Pharmaceutical Packaging Growth Opportunities
The Growing Pipeline of Temperature-sensitive Biologics Products and Healthcare Stakeholders’ Higher Stake in Patient Health Outcomes will Drive Investments
The COVID-19 pandemic has not only revealed supply chain challenges in terms of meeting pandemic-induced demand but also showcased weaknesses with regard to facing disruptions on a global scale. Immediate impacts include supply volatility, steep price increases, and high levels of uncertainty. Despite the manufacturing reboot, supply chain inter...
$2,450.00
Special Price $1,837.50 save 25 %
-
19 Aug 2022  |  North America  |  Market Research
Global Antibody Therapeutics Growth Opportunities
The Evolution of Next-generation Immuno-oncology Therapies for Multiple Tumor Antigens is Poised to Drive Market Growth
Market growth is likely to be fueled by the growing utilization of cost-effective and efficient continuous manufacturing processes and single-use bioreactors for production, which will also reduce the time between development and commercialization. Favorable regulatory reforms in emerging Asian countries are encouraging the manufacture and introduc...
$2,450.00
Special Price $1,837.50 save 25 %
-
19 Feb 2021  |  North America  |  Market Research
Regulatory and Infrastructure Reforms in India and China Catalyzing the Asian Specialty Generics Market
High Unmet Needs in Niche Oncology Indications will Drive Future Growth Potential
Frost & Sullivans Transformational Health team provides critical insights into the Asian specialty generics market with this research service, highlighting growth opportunities, selected countries biopharmaceutical environment, and significant R&D, regulatory, and infrastructure reforms influencing its growth. The report examines similarities and c...
$2,450.00
Special Price $1,837.50 save 25 %
-
13 May 2021  |  Global  |  Market Research
Post-COVID-19 Trends Disrupt the Global Contract Research Organization (CRO) Market
Increased Focus on Patient Centricity and Diversity in Clinical Trials Provide Growth Opportunities for CROs and Technology Vendors
Frost & Sullivan presents post-COVID-19 growth opportunities and strategic imperatives in the contract research organization (CRO) market, covering the markets maturity, key participants, competitive landscape, and recent mergers and acquisitions. The study highlights key growth drivers and restraints, identifies initiatives by major global CROs, a...
$4,950.00
Special Price $3,712.50 save 25 %
-
09 Apr 2018  |  North America  |  Market Outlook
Global Life Sciences Industry Outlook, 2018
Global Life Sciences Industry to Reach $1.5 T by 2022, Driven by Innovative Google, Amazon, Facebook, Apple (GAFA) Partnerships and R&D IT Investments
The global life sciences industry is onto a rocking start with the surge in CEO confidence from US tax reforms, rollicking equity markets and strengthening the global economy. Healthcare digitization, democratization creating explosion in patient data, emergence of value-based reimbursement models, and healthcare consumerism shifting the risk from ...
$4,950.00
Special Price $3,712.50 save 25 %
-
13 Sep 2021  |  North America  |  Market Research
Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Growth Opportunities
Emerging Pharmaceuticals and Highly Potent Complex Molecules Creating Future Growth Potential
This study presents Frost & Sullivan’s overall market and segment-wise revenue forecasts of the global small molecule contract development and manufacturing organization (CDMO) industry. It highlights key growth opportunities for small molecule CDMOs based on the main evolution in their business models and strategic approaches as well as those of p...
$4,950.00
Special Price $3,712.50 save 25 %
-
21 Aug 2020  |  Global  |  Market Research
Hybridization of Clinical Trial Designs Reviving Global CRO Market Post-pandemic, 2019–2024
Patient-centric and Safety-focused Logistical Solutions will Create New Growth Opportunities
In this research deliverable, Frost & Sullivan’s analyst team offers a bold perspective on the post-pandemic growth opportunities for the global CRO market. With the increased threat of COVID-19 and world-wide lockdowns in effect, the contract research organization (CROs) market is seeing interruptions in ongoing clinical trials and delays of new t...
$4,950.00
Special Price $3,712.50 save 25 %
-
26 Nov 2021  |  Europe  |  Market Research
EU COVID-19 Vaccine and Therapeutics Insights, Trends, and Growth Opportunities
Future Growth Potential Driven by Capabilities and Expertise in Vaccine Manufacturing
With this research service, Frost & Sullivan’s Healthcare and Life Sciences team provides critical insights into the European Union and UK COVID-19 vaccine and therapeutics market. The report analyzes COVID-19 vaccines and therapeutics in development and delves into supply chain considerations and requirements to manage distribution. Importantly, t...
$2,450.00
Special Price $1,837.50 save 25 %
-
20 Dec 2022  |  Global  |  Technology Research
Advances and Growth Opportunities in RNA Vaccines
Technology Innovations and Investments Bolster Next-generation Prophylactic and Therapeutic RNA Vaccines
RNA therapeutics and vaccines have been around for a long time, but the COVID-19 pandemic enabled their mass-market commercialization. Industry players saw mRNA vaccines developed for COVID-19 as effective for reducing the impact of the SARS-CoV-2 virus in populations. Moderna emerged as the first player to develop and commercialize an mRNA vaccine...
$4,950.00
Special Price $3,712.50 save 25 %